Antiplatelet and Anticoagulation Therapy

Aspirin has been in clinical use for over 100 years, making it one of the oldest commonly used drugs in medicine, and is now predominantly used as an antiplatelet agent. Major new antiplatelet drug classes have recently become available for the clinician that offer the promise of major improvements...

Full description

Bibliographic Details
Other Authors: Ferro, Albert (Editor), Garcia, David A. (Editor)
Format: eBook
Language:English
Published: London Springer London 2013, 2013
Edition:1st ed. 2013
Series:Current Cardiovascular Therapy
Subjects:
Online Access:
Collection: Springer eBooks 2005- - Collection details see MPG.ReNa
LEADER 02945nmm a2200301 u 4500
001 EB000363285
003 EBX01000000000000000216337
005 00000000000000.0
007 cr|||||||||||||||||||||
008 130626 ||| eng
020 |a 9781447142973 
100 1 |a Ferro, Albert  |e [editor] 
245 0 0 |a Antiplatelet and Anticoagulation Therapy  |h Elektronische Ressource  |c edited by Albert Ferro, David A. Garcia 
250 |a 1st ed. 2013 
260 |a London  |b Springer London  |c 2013, 2013 
300 |a X, 247 p. 37 illus., 26 illus. in color  |b online resource 
505 0 |a Antiplatelet agents: current and novel -- Antiplatelet Drug Resistance and Variability in Response: The Role of Antiplatelet Therapy Monitoring -- Anticoagulant Drugs: Current and Novel -- Primary prevention of cardiovascular disease -- Approaches to the Prophylaxis and Treatment of Venous and Cardiac Thromboembolic Disease 
653 |a Cardiology 
653 |a Medical sciences 
653 |a Health Sciences 
700 1 |a Garcia, David A.  |e [editor] 
041 0 7 |a eng  |2 ISO 639-2 
989 |b Springer  |a Springer eBooks 2005- 
490 0 |a Current Cardiovascular Therapy 
028 5 0 |a 10.1007/978-1-4471-4297-3 
856 4 0 |u https://doi.org/10.1007/978-1-4471-4297-3?nosfx=y  |x Verlag  |3 Volltext 
082 0 |a 616.12 
520 |a Aspirin has been in clinical use for over 100 years, making it one of the oldest commonly used drugs in medicine, and is now predominantly used as an antiplatelet agent. Major new antiplatelet drug classes have recently become available for the clinician that offer the promise of major improvements in the treatment and prevention of arterial thrombotic disease. In the field of anticoagulation, the vitamin K antagonists such as warfarin have not been available for as long as aspirin in the antiplatelet field, and have also had very little in the way of competition until recently; although a number of parenteral anticoagulants have been available, the vitamin K antagonists have been the only orally active anticoagulant drugs. The last few years have seen the arrival of new drug classes, the orally active direct thrombin inhibitors and factor Xa antagonists, which offer a number of advantages, but not without important drawbacks. In the face of these important advances in both antiplatelet and anticoagulant therapy, clinicians often feel confused, even overwhelmed, as to what is now available and which drugs are useful (and indicated) in which circumstances. Antiplatelet and Anticoagulant Therapy is designed with such people in mind. It is written in an easy-to-follow format and with many illustrations to aid clarity and the assimilation of information. Each chapter is written by established authorities in their fields who are also experienced in explaining often complex concepts. The result is a unique book which is not only comprehensive but also clear and useful for the busy medical practitioner